Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;45(6):1137-1153.
doi: 10.1007/s13402-022-00723-3. Epub 2022 Nov 3.

Role of nerves in neurofibromatosis type 1-related nervous system tumors

Affiliations
Review

Role of nerves in neurofibromatosis type 1-related nervous system tumors

Ling-Ling Ge et al. Cell Oncol (Dordr). 2022 Dec.

Abstract

Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder that affects nearly 1 in 3000 infants. Neurofibromin inactivation and NF1 gene mutations are involved in various aspects of neuronal function regulation, including neuronal development induction, electrophysiological activity elevation, growth factor expression, and neurotransmitter release. NF1 patients often exhibit a predisposition to tumor development, especially in the nervous system, resulting in the frequent occurrence of peripheral nerve sheath tumors and gliomas. Recent evidence suggests that nerves play a role in the development of multiple tumor types, prompting researchers to investigate the nerve as a vital component in and regulator of the initiation and progression of NF1-related nervous system tumors.

Conclusion: In this review, we summarize existing evidence about the specific effects of NF1 mutation on neurons and emerging research on the role of nerves in neurological tumor development, promising a new set of selective and targeted therapies for NF1-related tumors.

Keywords: Glioma; Nerve; Nervous system tumors; Neurofibromatosis type 1; Peripheral nerve sheath tumor.

PubMed Disclaimer

Similar articles

Cited by

References

    1. P.J. Cimino, D.H. Gutmann, Neurofibromatosis type 1, Handbook of clinical neurology 148, 799–811 (2018) https://doi.org/10.1016/b978-0-444-64076-5.00051-x
    1. J.M. Friedman, Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet. 89, 1–6 (1999) - DOI
    1. E. Rad, A.R. Tee, Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Semin. Cell Dev. Biol. 52, 39–46 (2016). https://doi.org/10.1016/j.semcdb.2016.02.007 - DOI
    1. G.A. Mashour, P.H. Driever, M. Hartmann, S.N. Drissel, T. Zhang, B. Scharf, U. Felderhoff-Müser, S. Sakuma, R.E. Friedrich, R.L. Martuza, V.F. Mautner, A. Kurtz, Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin. cancer research: official J. Am. Association Cancer Res. 10, 5677–5683 (2004). https://doi.org/10.1158/1078-0432.Ccr-03-0769 - DOI
    1. D.H. Gutmann, R.E. Ferner, R.H. Listernick, B.R. Korf, P.L. Wolters, K.J. Johnson, Neurofibromatosis type 1. Nat. Rev. Dis. Primers 3, 17004 (2017). https://doi.org/10.1038/nrdp.2017.4 - DOI

Substances

LinkOut - more resources